Abstract: The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.

Abstract: A method of scheduling cyclic steaming of petroleum-containing wells including: inputting to a production-predictor data describing the past cyclic steaming and resulting production of wells; processing the data in the production-predictor and outputting production predictions for the wells during a future steaming cycle; inputting the production predictions into an optimizer; inputting an initial steaming Optimal Cycle Length schedule for the wells into the optimizer; processing the production predictions and the initial steaming cycle schedule in the optimizer by: determining a ranking for the initial steaming cycle schedule for the production predictions against a pre-determined ranking criteria; producing new steaming cycle schedules based on the ranking of the initial steaming cycle a schedule optimization algorithm; determining a ranking for the new steaming schedules against the ranking criteria; repeating the production of schedules and determining ranking steps until some pre-determined termination c

Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.

Abstract: The invention relates to substituted phenylacetic acids as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.

Abstract: Automated medical diagnostic interpretation and report generation for a non-invasive medical diagnostic test, such as an echo cardiogram, is provided. Various dimension measurements and physiological measurements from an echo cardiogram machine are transferred automatically to a computer over an echo cardiogram machine interface. The dimensions and physiological measurements are automatically interpreted by an intelligent interpretation engine running on a computer, generating various machine evaluations. The physician can approve the machine evaluations, overrule them, or make appropriate adjustments. Upon completion of the physician's review, the physician approved interpretations become diagnostic conclusions, and the report containing the results of the physician's review is generated by the report generation engine.

Abstract: The present invention relates to amide compounds useful as pharmaceuticals for treating respiratory disorders such as asthma, rhinitis and COPD.

Abstract: The present invention therefore provides a compound of formula (I) and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.

Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.

Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.

Abstract: A method and system of sending supplemental information during a telecommunications session includes the step (305) of detecting a period of silence within the telecommunications session. The period of silence can be detected from at least one member of the telecommunications session. Comfort noise can be specified within at least one time slot (205) of a plurality of consecutive time slots (205, 210) for a channel over which the period of silence is detected. For at least one other time slot of the channel (210), non-voice data is specified such that the channel includes both comfort noise and other non-voice data during the period of silence. The consecutive time slots (205, 210) can be associated with a data block (200). The non-voice data can be a data payload of the other time slot (210).

Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.

Abstract: The invention relates to substituted acids of formula (I), where T, W, X, Y, Z, R1 and R2 as defined in the claims, as useful pharmaceutical compounds for treating asthma and rhinitis, pharmaceutical compositions containing them, and a processes for their preparation.

Abstract: A pump including a pump housing, a fluid inlet, a fluid outlet, a pumping chamber in fluid communication with both the fluid inlet and the fluid outlet, a motor for pumping a working fluid, and a plate that is at least partially constructed of a heat conductive material and that at least partially defines the pumping chamber. The plate can transfer heat from the motor to the working fluid in the pumping chamber.

Abstract: The invention relates to certain 2-substituted phenoxyacetic acid derivatives of formula (I), in which the variables are as defined in the claims, useful in the treatment of diseases or conditions in which modulation of the CRTh2 receptor is beneficial, such as asthma and rhinitis.

Abstract: The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.

Abstract: The present invention therefore provides use of a compound of formula (I) and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S.

Abstract: A wireless local area network (WLAN) mobile station (110, 112, 114) has an application processor core (204) and a WLAN processor (202). So as to conserve energy, when the two processors are not needed, they are both placed in a minimal power consumption mode. The WLAN processor operates a WLAN radio and receives beacon transmissions from an access point (120). Upon extracting the beacon data from a received beacon signal, the WLAN processor passes the beacon data to the application processor. To ensure receipt of the beacon data, the WLAN processor remains active until the application processor acknowledges receipt of the beacon data before transitioning back to a sleep mode. To prevent keeping the WLAN processor waiting longer than necessary, the application processor wakes up ahead of the beacon receipt time, in time to allow transition to an awake mode so that it is active by the time the WLAN processor passes the beacon data.

Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.

Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.

Abstract: The present invention therefore provides use of a compound of formula (I) and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition, this invention also discloses processes for the preparation of such inhibitors.